Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Welcome to BioNTech’s Fourth Quarter and Full-Year 2024 Earnings ...

Truist analyst Asthika Goonewardene lowered the firm’s price target on BioNTech (BNTX) to $151 from $172 and keeps a Buy rating on the shares.

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...

Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...

When the European Union pours money into start-ups, it doesn’t just fund ideas—it unlocks immense value. A new report by ...

Three-member expert panel will oversee process to dispose of the Sinovac-CoronaVac doses that expired in December 2023.

As we reflect on five years of COVID-19, it’s clear that the impacts are still unfolding. The life sciences—and we as ...

Nigeria is missing from the list of countries on track to secure the World Health Organisation (WHO) vaccine approval due to ...

The first confirmed COVID-19 case in the Ottawa region was announced five years ago on Tuesday, the same day the World Health ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

An Indian origin scientist Vinod Balachandran, MD, in latest data from the phase 1 trial has revealed that an investigational ...

Pfizer (NYSE:PFE) announced positive outcomes from the Phase 3 VERITAC-2 clinical trial, showing vepdegestrant's promise in ...